New award for venlafaxine hydrochloride (HCL) 24HR sustained action (SA) capsules with puracap laboratories, LLC DBA BLU pharmaceuticals. Period of performance is AUG. 30, 2026 to AUG. 29, 2026 with…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0035
- Awardee
-
Puracap Laboratories LLC UEI CMJ7J1HLH9N4
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Venlafaxine 24HR Sustained Action Capsules Pre-Solicitation · 36E79726R0010 · Posted Feb 5, 2026
- Last date to order 13% complete
- IDV ceiling
- $32,351,492.75
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Puracap Laboratories LLC, doing business as BLU Pharmaceuticals, for the supply of Venlafaxine Hydrochloride 24-hour sustained-action capsules on August 30, 2026, with a ceiling value of $32,351,492.75.
The contract carries no set-aside designation and is unrestricted. Performance occurs nationwide through the Department of Veterans Affairs (including Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution handled through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
The solicitation (RFP 36E79726R0010) called for supply of three strength formulations (37.5 mg, 75 mg, and 150 mg) in multiple package sizes (30, 90, 500, and 1,000 capsules per bottle), with estimated annual requirements of approximately 730,000 bottles. All unit-of-use packaging for 30 and 90 count bottles must include safety caps convertible to non-safety caps and meet specific bottle specifications including a minimum 120 cc volume and capacity for labels measuring 5.25 by 2 inches. The RFP was issued in commercial item format under FAR Part 12.
The contract period runs from August 30, 2026, through August 29, 2027, with four pre-priced one-year option periods, providing a maximum five-year term.
Description
New award for venlafaxine hydrochloride (HCL) 24HR sustained action (SA) capsules with puracap laboratories, LLC DBA BLU pharmaceuticals. Period of performance is AUG. 30, 2026 to AUG. 29, 2026 with four one-year options.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0035?
36E79726D0035 was awarded to Puracap Laboratories LLC by National Acquisition Center (Headquarters) on August 30, 2026.
How much is contract 36E79726D0035 worth?
36E79726D0035's own ceiling is $32,351,493.
Who can order from contract 36E79726D0035?
36E79726D0035 is a single award indefinite delivery contract.
Was contract 36E79726D0035 competed?
The extent of competition for 36E79726D0035 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV